InSTAR Program, Department of Psychiatry, NIMHANS, Bangalore
  • Home
  • About InSTAR
  • InSTAR Team
    • Psychiatry
    • Psychiatric Social Work
    • Clinical Psychology
  • Program Advisors
  • Schizophrenia Clinic
  • Metabolic Clinic
  • Family Interventions
  • Cognitive Therapies
  • Yoga Therapy
  • WISER Program
  • ORACLES
  • Academics & Training
  • Research
  • Publications
  • Venue & Timings
  • Contact Info

InSTAR - Research Publications

  1. Narayanaswamy JC, Shivakumar V, Bose A, Agarwal SM, Venkatasubramanian G, Gangadhar BN. Sustained Improvement of Negative Symptoms in Schizophrenia with Add-on tDCS: A Case Report. Clinical Schizophrenia And Related Psychoses (accepted for publication).
  2. Shivakumar V, Narayanaswamy JC, Agarwal SM, Bose A, Subramaniam A, Venkatasubramanian G. Targeted, Intermittent Booster tDCS: A Novel Add-on Application for Maintenance Treatment in a Schizophrenia Patient with Refractory Auditory Verbal Hallucinations. Asian Journal of Psychiatry (accepted for publication).
  3. Sharma E, Venkatasubramanian G, Varambally S, Sivakumar P.T., Subbakrishna D.K., Gangadhar B.N. Antipsychotic Induced Metabolic Changes & Treatment Response: A Prospective Study. Asian Journal of Psychiatry (accepted for publication).
  4. Response Letter Sharma E, Rao NP, Venkatasubramanian G. Association between Antipsychotic-induced Metabolic Side-effects and Clinical Improvement: A Review on the Evidence for “Metabolic Threshold”. Asian Journal of Psychiatry 2014;8:12-21.
  5. Amaresha AC, Danivas V, Shivakumar V, Agarwal SM, Kalmady SV, Narayanaswamy JC, Venkatasubramanian G. Clinical Correlates of Parametric Digit-Symbol Substitution Test in Schizophrenia. Asian Journal of Psychiatry (accepted for publication).
  6. Amaresha AC, Venkatasubramanian G, Muralidhar D. Needs of Siblings of Persons With Psychosis: A Systematic Descriptive Review. Clinical Psychopharmacology & Neurosciences 2014 (Accepted for publication).
  7. Narayanaswamy JC, Kalmady SV, Venkatasubramanian G, Gangadhar BN. Clinical Correlates of Superior Temporal Gyrus Volume Abnormalities in Antipsychotic-naïve Schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences (accepted for publication)
  8. Shivakumar V, Kalmady SV, Venkatasubramanian G, Ravi V, Gangadhar BN. Do Schizophrenia Patients Age Early? Asian Journal of Psychiatry (accepted for publication)
  9. Kalmady SV, Venkatasubramanian G, Shivakumar V, Gautham S, Subramaniam A, Jose DA, Maitra A, Ravi V, Gangadhar BN. Relationship between Interleukin-6 Gene Polymorphism and Hippocampal Volume in Antipsychotic-naïve Schizophrenia: Evidence for Differential Susceptibility?  PLOS One;9(5):e96021.
  10. Arasappa R, Rao NP, Venkatasubramanian G, Reddy NN, Behere RV, Sivakumar PT, Gangadhar BN. Rimonabant-induced depression in schizophrenia. Indian J Psychiatry. 2014 Apr;56(2):205.
  11. Venkatasubramanian G, Debnath M. Neuroimmunological Aberrations & Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis. Clinical Psychopharmacology & Neurosciences. 2014;12(1):8-18. 
  12. Bose A, Shivakumar V, Narayanaswamy JC, Nawani H, Subramaniam A, Agarwal SM, Chhabra H, Kalmady SV, Venkatasubramanian G. Insight facilitation with add-on tDCS in Schizophrenia. Schizophrenia Research 2014;156(1):63-65.
  13. Nawani H, Bose, Agarwal SM, Shivakumar V, Chhabra H, Subramaniam A, Kalmady S, Narayanaswamy JC, Venkatasubramanian G. Modulation of Corollary Discharge Dysfunction in Schizophrenia by tDCS: Preliminary Evidence. Brain Stimulation 2014;7(3):486-488.
  14. Vijay Kumar, et al, Venkatasubramanian G. Antipsychotic induced Restless Legs Syndrome (RLS) treated with Gabapentin: a case report. Asian Journal of Psychiatry 2014;9:89-90.
  15. Bose A, Agarwal SM, Kalmady SV. Venkatasubramanian G. Cognitive Mapping Deficits in Schizophrenia: A Critical Overview. Indian Journal of Psychological Medicine 2014;36(1):9-26.
  16. Agarwal SM, Shivakumar V, Bose A, Subramaniam A, Nawani H, Chhabra H, Kalmady SV, Narayanaswamy JC, Venkatasubramanian G. Transcranial Direct Current Stimulation in Schizophrenia – A Review. Clinical Psychopharmacology and Neuroscience 2013;11(3):118-125.
  17. Sharma E, Rao NP, Venkatasubramanian G. Association between Antipsychotic-induced Metabolic Side-effects and Clinical Improvement: A Review on the Evidence for “Metabolic Threshold”. Asian Journal of Psychiatry 2014;8:12-21.
  18. Kumar D, Rao M, Raveendranathan D, Venkatasubramanian G, Varambally S, Gangadhar B. Metacognitive training for delusion in treatment resistant schizophrenia. Clin Schizophr Relat Psychoses. 2013 Mar 21:1-11. 
  19. Meherwan Mehta U, Agarwal SM, Kalmady SV, Shivakumar V, Kumar CN, Venkatasubramanian G, Thirthalli J, Gangadhar BN, Pascual-Leone A, Keshavan MS. Enhancing putative mirror neuron activity with magnetic stimulation: a single-case functional neuroimaging study. Biol Psychiatry. 2013 Aug 1;74(3):e1-2. 
  20. Venkatasubramanian G, Debnath M. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul;44:301-11.
  21. Dhandapani A, Narayanaswamy JC, Venkatasubramanian G. Adjuvant raloxifene treatment for negative symptoms of schizophrenia. Asian J Psychiatr. 2013Jun;6(3):254-5. 
  22. Jayaram N, Rao MG, Narasimha A, Raveendranathan D, Varambally S, Venkatasubramanian G, Gangadhar BN. Vitamin B₁₂ levels and psychiatric symptomatology: a case series. J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):150-2. 
  23. Danivas V, Venkatasubramanian G. Current perspectives on chlorpromazine equivalents: Comparing apples and oranges! Indian J Psychiatry. 2013 Apr;55(2):207-8. 
  24. Raveendranathan D, Shiva L, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN. Clozapine-induced restless legs syndrome treated with aripiprazole. J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E62-3. 
  25. Raveendranathan D, Shiva L, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN. Vitamin B₁₂ deficiency masquerading as clozapine-resistant psychotic symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):E34-5. 
  26. Divakaran A, Narayanaswamy JC, Kalmady SV, Narayan V, Rao NP, Venkatasubramanian G. Family history correlates of digit ratio abnormalities in schizophrenia. Indian J Psychol Med. 2012 Oct;34(4):355-9. 
  27. Danivas V, Kalmady SV, Venkatasubramanian G, Gangadhar BN. Thalamic shape abnormalities in antipsychotic naïve schizophrenia. Indian J Psychol Med. 2013 Jan;35(1):34-8. 
  28. Kalmady SV, Venkatasubramanian G, Shivakumar V, Jose D, Ravi V, Gangadhar BN. Relationship between Brain-Derived Neurotrophic Factor and Schneiderian First Rank Symptoms in Antipsychotic-Naïve Schizophrenia. Front Psychiatry. 2013 Jul2;4:64. 
  29. Debnath M, Venkatasubramanian G. Recent advances in psychoneuroimmunology relevant to schizophrenia therapeutics. Curr Opin Psychiatry. 2013Sep;26(5):433-9. 
  30. Shivakumar V, Bose A, Rakesh G, Nawani H, Subramaniam A, Agarwal SM, Kalmady SV, Narayanaswamy JC, Venkatasubramanian G. Rapid improvement of auditory verbal hallucinations in schizophrenia after add-on treatment with transcranial direct-current stimulation. J ECT. 2013 Sep;29(3):e43-4.
  31. Hariprasad VR, Varambally S, Shivakumar V, Kalmady SV, Venkatasubramanian G, Gangadhar BN. Yoga increases the volume of the hippocampus in elderly subjects. Indian J Psychiatry. 2013 Jul;55(Suppl 3):S394-6.
  32. Jayaram N, Varambally S, Behere RV, Venkatasubramanian G, Arasappa R, Christopher R, Gangadhar BN. Effect of yoga therapy on plasma oxytocin and facial emotion recognition deficits in patients of schizophrenia. Indian J Psychiatry. 2013 Jul;55(Suppl 3):S409-13. 
  33. Agarwal SM, Venkatasubramanian G. Metabolic syndrome in schizophrenia: theoretical, clinical and translational perspectives. Indian J Psychol Med. 2013 Apr;35(2):117-20. 
  34. Nawani H, Kalmady SV, Bose A, Shivakumar V, Rakesh G, Subramaniam A, Narayanaswamy JC, Venkatasubramanian G. Neural Basis of tDCS Effects on Auditory Verbal Hallucinations in Schizophrenia : A Case Report Evidence for Cortical Neuroplasticity Modulation. J ECT. 2014;30(1) e2-4.
  35. Divakaran A, Narayanaswamy JC, Kalmadi SV, Narayan V, Rao NP, Venkatasubramanian G. Parent-of-origin Effect in Schizophrenia and Non-affective Psychoses: Evidence from Dermatoglyphics. Indian J Psychol Med. 2013 Jul;35(3):260-7. 
  36. Mehta UM, Naveen Kumar C, Venkatasubramanian G, Thirthalli J. Multimodal Sensory Distortions in Post-partum Exacerbation of Schizophrenia. Clin Schizophr Relat Psychoses. 2013 Nov 25:1-9. 
  37. Rakesh G, Shivakumar V, Subramaniam A, Nawani H, Amaresha AC, Narayanaswamy JC, Venkatasubramanian G. Monotherapy with bifocal tDCS for Schizophrenia: A Case Report. Brain Stimulation 2013 Jul;6(4):708-9.
  38. Rao VMG, Varambally S, Raveendranathan D, Venkatasubramanian G, Gangadhar BN. Trihexyphenidyl use and dependence - A Case Report.  Mental Health and Substance Use (in press).
  39. Kalmady SV, Agarwal SM, Shivakumar V, Jose D, Venkatasubramanian G, Janardhan Reddy YC. Revisiting Geschwind’s Hypothesis on Brain Lateralization: A Functional MRI Study Of Digit Ratio (2D:4D) & Sex Interaction Effects on Spatial Working Memory. Laterality (accepted for publication).
  40. Debnath M, Cannon DM, Venkatasubramanian G. Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2012 (in press)
  41. Arasappa R, Danivas V, Venkatasubramanian G. Choroid plexus papilloma presenting as schizophrenia: A case report. The Journal of Neuropsychiatry and Clinical Neurosciences 2012 (accepted for publication).
  42. Shivakumar V, Venkatasubramanian G. Successful Use of Adjuvant Raloxifene Treatment in Clozapine Resistant Schizophrenia. Indian Journal of Psychiatry 2012 (accepted for publication)
  43. Agarwal SM, Rao NP, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN. Successful use of modafinil in treatment-resistant bipolar depression in elderly woman. Indian Journal of Psychiatry (accepted for publication)
  44. Raveendranathan D, Varambally S, Venkatasubramanian G, Rao MG, Gangadhar BN. Atomoxeting induced vocal tics in a patient with schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences (accepted for publication)
  45. Virupaksha HS, Kalmady SV, Shivakumar V, Arasappa R, Venkatasubramanian G, Gangadhar BN. Volume & Asymmetry Abnormalities of Insula in Antipsychotic-naïve Schizophrenia: A 3-Tesla MRI Study. Indian Journal of Psychological Medicine (in press)
  46. Jhamnani K, Shivakumar V, Kalmady S, Rao NP, Venkatasubramanian G. Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences (accepted for publication)
  47. Rao MG, Rohilla J, Varambally S, Raveendranathan D, Venkatasubramanian G, Gangadhar BN.  Thyrotoxicosis presenting as mixed affective state: a case report. Gen Hosp Psychiatry. 2012 Apr 18. [Epub ahead of print]
  48. Sam PJ, Sharma E, Narayanaswamy JC, Rajendran V, Kalmady SV, Rao NP, Venkatasubramanian G, Gangadhar BN. Entorhinal Cortex Volume in antipsychotic-naïve schizophrenia. Indian Journal of Psychological Medicine 2012 (accepted for publication).
  49. Narayanaswamy JC, Venkatasubramanian G, Gangadhar BN. Neuroimaging Research in Schizophrenia: An Overview of studies from Asia. International Review of Psychiatry (accepted for publication)
  50. Venkatasubramanian G, Jayakumar PN, Keshavan MS, Gangadhar BN. Schneiderian First Rank Symptoms & Inferior Parietal Lobule Cortical Thickness in Antipsychotic-naïve Schizophrenia. Progress in Neuropsychopharmacology& Biological Psychiatry 2011;35(1):40-46.
  51. Venkatasubramanian G, Arasappa R, Rao NP, Gangadhar BN. Digit Ratio (2D:4D) Asymmetry &Schneiderian First Rank Symptoms: Implications for Cerebral lateralization theories of Schizophrenia. Laterality 2011; 16(4):499-512.
  52. Venkatasubramanian G, Chittiprol S, Neelakantachar N, Shetty T, Gangadhar BN. Effect of Antipsychotic Treatment on Insulin-like Growth Factor-1 and Cortisol in Schizophrenia: A Longitudinal Study Schizophrenia Research 2010;119(1-3):131-137.
  53. Venkatasubramanian G, Jayakumar PN, Reddy VV, Reddy US, Gangadhar BN, Keshavan MS. Corpus Callosum Deficits in Antipsychotic-naïve Schizophrenia: Evidence for Neurodevelopmental Pathogenesis. Psychiatry Research: Neuroimaging 2010;182(2):142-145.
  54. Venkatasubramanian G, Puthumana DTK, Jayakumar PN, Gangadhar BN. A functional MRI study of neurohaemodynamic abnormalities during emotion processing in subjects at high risk for schizophrenia. Indian Journal of Psychiatry 2010 Oct;52(4):308-15.
  55. Venkatasubramanian G. Neuroanatomical Correlates of Psychopathology in Antipsychotic-naïve schizophrenia. Indian Journal of Psychiatry 2010;52(1):28-36. 
  56. Venkatasubramanian G, Arasappa R, Rao NP, Behere RV, Kalmady S, Gangadhar BN. Inverse Relationship between Serum High Density Lipoprotein and negative syndrome in Antipsychotic-naïve Schizophrenia. Clinical Chemistry & Laboratory Medicine 2010;48(1):95-98.
  57. Venkatasubramanian G, Arasappa R, Christopher R, Gangadhar BN. Neuropharmacology of Schizophrenia: Is there a role for leptin? Clinical Chemistry & Laboratory Medicine 2010;48(6):895-96.
  58. Venkatasubramanian G. Pharmacological Pleiotropy and Antagonistic Co-evolutionary Processes: A Useful Hypothetical Model for Applied Evolutionary Medicine. ActaClinicaBelgica 2010;65(1):62-3.
  59. Venkatasubramanian G, Kalmady SV. Creativity, Psychosis & Human Evolution: The Exemplar Case of Neuregulin 1 Gene. Indian Journal of Psychiatry 2010;52(3):282.
  60. Venkatasubramanian G. Early intervention in psychosis: Perspectives on Asian studies. Asian Journal of Psychiatry 2012; 5:1-2.
  61. Venkatasubramanian G. The ‘Holy Grail’ and ‘Poisoned Chalice’ Effects of Antipsychotics on Oxidative Stress: Can ‘Hormesis’ explain this paradox? Indian Journal of Psychological Medicine 2012;34(1):97-98.
  62. Venkatasubramanian G, Arasappa R, Rao NP, Behere RV, Gangadhar BN. Adjuvant metformin worsens psychosis in schizophrenia: A case report. The Primary Care Companion to the Journal of Clinical Psychiatry 2010;12(2). pii: PCC.09l00801. 
  63. Venkatasubramanian G. Schizophrenia, Cancer & the “Red Queen” Co-Evolutionary Dynamics. Medical Hypotheses2009 Sep;73(3):460.
  64. Venkatasubramanian G. The ‘Boon & Bane’ of Antipsychotic-Induced Metabolic Syndrome. ActaPsychiatricaScandinavica 2009 Dec;120(6):500-1. 
  65. Varambally S, Venkatasubramanian G, Gangadhar BN. Neurological soft signs in schizophrenia: The past, present and the future. Indian Journal of Psychiatry 2012;54:73-80.
  66. Anekal AC, Venkatasubramanian G. Expressed Emotions in Schizophrenia: An Overview. Indian Journal of Psychological Medicine 2012;34:12-20.
  67. Rao NP, Venkatasubramanian G, Arasappa R, Gangadhar BN. Relationship between corpus callosum abnormalities and schneiderian first-rank symptoms in antipsychotic-naive schizophrenia patients. J Neuropsychiatry ClinNeurosci. 2011 Spring;23(2):155-62.
  68. Danivas V, Kalmady SV, Arasappa R, Behere RV, Rao NP, Venkatasubramanian G, Gangadhar BN. Inferior Parietal Lobule volume and Schneiderian First-Rank Symptoms in Antipsychotic-naive Schizophrenia: A 3-tesla MRI study. Indian Journal of Psychological Medicine 2009 Jul;31(2):82-87.
  69. Behere RV, Kalmady SV, Venkatasubramanian G, Gangadhar BN. Orbitofrontal lobe volume deficits in antipsychotic-naïve schizophrenia: A 3-tesla MRI study. Indian Journal of Psychological Medicine 2009 Jul;31(2):77-81.
  70. Rao NP, Kalmady SV, Arasappa R, Venkatasubramanian G, Gangadhar BN. Clinical correlates of Thalamus volume deficits in Antipsychotic-naïve Schizophrenia: A 3 Tesla MRI Study. Indian Journal of Psychiatry 2010;52(3):229-235.
  71. Jayakumar PN, Gangadhar BN, Venkatasubramanian G, Desai S, Velayudhan L, Subbakrishna D, Keshavan MS. High Energy Phosphate Abnormalities Normalize after Antipsychotic Treatment in Schizophrenia: A Longitudinal 31P MRS Study of Basal Ganglia. Psychiatry Research: Neuroimaging 2010;181(3):237-240.
  72. Chittiprol S, Venkatasubramanian G, Neelakantachar N, Babu SV, Reddy NA, Shetty KT, Gangadhar BN. Oxidative Stress &Neopterin Abnormalities in Schizophrenia: A Longitudinal Study. J Psychiatr Res. 2010 Apr;44(5):310-3.
  73. Chittiprol S, Venkatasubramanian G, Neelakantachar N, Allha N, Shetty KT, Gangadhar BN.  Longitudinal Study of β2-Microglobulin Abnormalities in Schizophrenia. International Immunopharmacology 2009 Sep;9(10):1215-7.
  74. Joseph AM, Venkatasubramanian G, Sharma PS. A six-to-ten weeks' follow-up study on the effects of olanzapine on abdominal fat and other metabolic parameters in patients with psychoses--an imaging-based study with controls. East Asian Arch Psychiatry. 2011 Mar;21(1):10-6.
  75. Behere RV, VenkatasubramanianG, Arasappa R, Reddy NN, Gangadhar BN. Effect Of Risperidone On Emotion Recognition Deficits In Antipsychotic-Naïve Schizophrenia: A Short-Term Follow-Up Study. Schizophrenia Research 2009 Aug;113(1):72-6.  
  76. Behere RV, Venkatasubramanian G, Arasappa R, Reddy NN, Gangadhar BN. First rank symptoms & facial emotion recognition deficits in antipsychotic naïve schizophrenia: Implications for social threat perception model. ProgNeuropsychopharmacolBiol Psychiatry. 2011 Aug 15;35(7):1653-8.
  77. Behere RV, Arasappa R, Jagannathan A, Varambally S, Venkatasubramanian G, Thirthalli J, Subbakrishna DK, Nagendra HR, Gangadhar BN. Effect of yoga therapy on facial emotion recognition deficits, symptoms and functioning in patients with schizophrenia.  ActaPsychiatr Scand. 2011 Feb;123(2):147-53.
  78. Rao NP, Arasappa R, Reddy NN, Venkatasubramanian G, Gangadhar BN. Antithetical Asymmetry in Schizophrenia and Bipolar affective disorder: A line bisection study. Bipolar Disorders 2010;12(3):221-229.
  79. Sharma E, Raveendranathan D, Shivakumar V, Jayaram N, Rao NP, Venkatasubramanian G. Beneficial Effects of Add-On Raloxifene in Schizophrenia: A Case Report. Archives of Women's Mental Health 2012; 15:147-148.
  80. Sharma E, Rao NP, Venkatasubramanian G, Behere RV, Varambally S, Sivakumar PT, Gangadhar BN. Relation between weight gain and clinical improvement: Is there a metabolic threshold for second generation antipsychotics? Psychiatry Research 2011; 186;155.
  81. Rao NP, Venkatasubramanian G, Gangadhar BN. Add-on Quetiapine for Difficult to Treat Bipolar Depression. German Journal of Psychiatry 2010;13(1):41-44.
  82. Saraf G, Behere RV, Venkatasubramanian G, Rao NP, Varambally S, Gangadhar BN. Hyperprolactinemia with aripiprazole: understanding the paradox. Am J Therapeutics. (In press)
  83. Kalyani BG, VenkatasubramanianG, Arasappa R, Rao NP, Kalmady SV, Behere RV, Rao H, Vasudev MK, Gangadhar BN. Neuro-hemodynamic Correlates of Om Chanting: A Pilot fMRI Study. International Journal of Yoga 2011 Jan;4(1):3-6.
  84. Agarwal SM, Rao NP, Jhamnani K, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN. Prolactin - a biomarker for antipsychotic treatment response? Primary care companion to CNS disorders 2011;13(4):e1.
  85. Agarwal SM, Rao NP, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN. Successful treatment of atypical depression with amisulpride: a case report. Asian journal of Psychiatry (In press)
  86. Rao NP, Venkatasubramanian G, Koparde V, Behere RV, Varambally S, Gangadhar BN. Risperidone treatment for polydipsia and hyponatremia in schizophrenia: a case report. Turk PsikiyatriDerg. 2011 Summer;22(2):123-5.
  87. Rao NP, Palaniyappan P, Chandur J, Venkatasubramanian G, Gangadhar BN. Successful Use of Donepezil in Treatment of Cognitive Impairment Caused by Maintenance Electroconvulsive Therapy-A Case Report. Journal of ECT 2009 Sep;25(3):216-8.
  88. Devi S, Behere RV, Varambally S, Rao NP, Venkatasubramanian G, Gangadhar BN. Physical deformity as sequela of chronic catatonia and response to electroconvulsive therapy: a case report.  J ECT. 2011 Sep;27(3):e49-50.
  89. Shivakumar V, Jayaram N, Rao NP, Venkatasubramanian G. Successful Use of Add-on Topiramate for antipsychotic-induced weight gain. Indian Journal of Psychological Medicine 2012;34(1):85-86.
  90. Behere RV, Anjith D, Rao NP, Venkatasubramanian G, Gangadhar BN. Olanzapine Induced Clinical Seizure: A Case Report. Clinical Neuropharmacology 2009 Sep-Oct;32(5):297-8.   
  91. Behere RV, Rao NP, Venkatasubramanian G. Annotations of Indian Journal of Psychiatry - Biological Investigations. Indian Journal of Psychiatry 2010;52(1):S104-S106.
  92. Rakesh G, Rao NP, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN. Treatment with phytoestrogens for depressive symptoms in late-onset schizophrenia:a case report. Prim Care Companion CNS Disord. 2011;13(3). pii: PCC.10l01123.
  93. Jayaram N, Rao NP, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN. Successful use of Aripiprazole for delusional disorder with co-morbid Pituitary microadenoma: A case report. Psychosomatics  2011 Jul-Aug;52(4):395-7.
  94. Rao NP, Antony A, Raveendranathan D, Venkatasubramanian G, Behere RV, Varambally SS, Gangadhar BN. Successful use of Maintenance ECT in the treatment of clozapine associated Obsessive compulsive symptoms in schizophrenia – A Case Report. Journal of ECT (In press)
  95. Rao NP, Kasal V, Mutalik RN, Behere RV, Venkatasubramanian G, Varambally S, Gangadhar BN. Has "Kahlbaum Syndrome" Disappeared or is it underdiagnosed? - Re-examining the nosology of catatonia.  Journal of ECT (In press)
  96. Vinay HR, KeerthiSundarGS, Behere RV, Arasappa R, Rao NP, Venkatasubramanian G, Sivakumar PT, Gangadhar BN. Effect Of Risperidone On Metabolic Parameters In Antipsychotic-Naīve Schizophrenia: A Prospective One Year Follow-Up Study. Asian Journal of Psychiatry 2011;4:73-74.
  97. Danivas V, Behere RV, Varambally S, Rao NP, Venkatasubramanian G, Gangadhar. ECT in Treatment of Delirious Mania: A Report of 2 cases. Journal of ECT 2010 Dec;26(4):278-9.
  98. Divakaran A, Rao NP, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN. Chlorpromazine Induced Cataract in a Young Patient with Schizophrenia:  A case report. Indian Journal of Psychological Medicine 2010;32(1):69.
  99. Sharma E, Rao NP, Venkatasubramanian G, Behere RV, VaramballySS,Gangadhar BN. Successful treatment of co-morbid Schizophrenia and Multiple Sclerosis. Asian Journal of Psychiatry 2010;3(4):235-36.
  100. Agarwal SM, Rao NP, Venkatasubramanian G. Clozapine: a friend estranged? Indian Journal of Psychiatry2011 Jul;53(3):274-275.
  101. Agarwal SM, Behere RV, Venkatasubramanian G, Rao NP, Varambally S, Gangadhar BN. Successful Treatment of Co-morbid Obesity & Polycystic Ovarian Disease with Add-on Metformin in Bipolar Affective Disorder. Prim Care Companion CNS Disorders. 2011;13(5):e1.
  102. Rao NP, DaNivas V, Venkatasubramanian G, Behere RV, Gangadhar BN. Co-morbid Bipolar disorder and Usher syndrome. The Primary Care Companion to the Journal of Clinical Psychiatry 2010;12(2). pii: PCC.09l00792.
  103. Rao NP, Mutalik NR, Kasal V, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN. Monocyte abnormality in catatonia: revisiting the immune theory of catatonia. J ECT. 2011 Sep;27(3):e53-4.
  104. Venkatasubramanian G. Triplex DNA, Human Evolution & Schizophrenia. ActaNeuropsychiatrica 2009;29:100-101. 
  105. Venkatasubramanian G. Reformulating Schizophrenia: The Importance of Evolutionary Theories. Medical Hypotheses 2009 Feb;72(2):229-30. 
  106. Venkatasubramanian G, Rao NP, Behere RV. Neuroanatomical, Neurochemical, and Neurodevelopmental Basis of Obsessive-Compulsive Symptoms in Schizophrenia. Indian Journal of Psychological Medicine 2009;31(1):1-8. 
  107. Kalmady SV, Venkatasubramanian G. Evidence for positive selection on Protocadherin Y gene in Homo sapiens: Implications for schizophrenia. Schizophrenia Research 2009 Mar;108(1-3):299-300.
  108. Venkatasubramanian G. Evolutionary perspectives on psychoses & autism: Does genomic imprinting contribute to phenomenological antithesis? Behavioral and Brain Sciences 2008;Jun;31(3):281-282.
  109. Thirthalli J, Venkatesh BK, Kishorekumar KV, Arunachala U, VenkatasubramanianG, Subbakrishna DK, Gangadhar BN. Prospective comparison of course of disability in antipsychotic-treated and untreated schizophrenia patients. Acta Psychiatrica Scandinavica 2009 Mar;119(3):209-17.
  110. Chittiprol S, Venkatasubramanian G, Neelakantachar N, Allha N, Shetty KT, Gangadhar BN. β2-Microglobulin Abnormalities in Antipsychotic-naïve Schizophrenia: Evidence for Immune Pathogenesis. Brain Behav Immun. 2009 Feb;23(2):189-92.
  111. Bharadwaj B, Arasappa R, Venkatasubramanian G, Gangadhar BN. Successful use of adjuvant phytoestrogens in schizoaffective disorder: A Case Report. The Primary Care Companion to the Journal of Clinical Psychiatry 2009;11(5):268.
  112. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS.  Automated MRI Parcellation Study of Regional Volume and Thickness of Prefrontal Cortex in Antipsychotic-Naïve Schizophrenia. ActaPsychiatricaScandinavica 2008;Jun;117(6):420-31.
  113. Venkatasubramanian G. Antipsychotic-induced weight gain in patients with schizophrenia. The Journal of the American Medical Association (JAMA) 2008 Apr 23;299(16):1899.
  114. Venkatasubramanian G, Jayakumar PN, Nagendra HR, Nagaraja D, Deeptha R, Gangadhar BN. Investigating the Paranormal Phenomena: Functional Brain Imaging of Telepathy. International Journal of Yoga 2008; Vol 1(2):66-71.
  115. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. Neuroanatomical correlates of neurological soft signs in antipsychotic-naïve schizophrenia. Psychiatry Research: Neuroimaging 2008 Dec 30;164(3):215-22.
  116. Behere RV, Raghunandan VNGP, Venkatasubramanian G, Subbakrishna DK, Jayakumar PN, Gangadhar BN. TRENDS - A Tool for Recognition of Emotions in Neuropsychiatric DisorderS. Indian Journal of Psychological Medicine 2008;30(1):32-38.
  117. Bharadwaj B, Arasappa R, Behere RV, Venkatasubramanian G, Jayakumar PN, Gangadhar BN. Emotion recognition deficits in anti-psychotic naïve schizophrenia. Indian Journal of Psychological Medicine 2008;30(2):21-28.
  118. Arasappa R, Rao NP, Venkatasubramanian G, Jayakumar PN, Gangadhar BN. Structural Cerebellar Abnormalities in Antipsychotic-naive schizophrenia: Evidence for Cognitive Dysmetria. Indian Journal of Psychological Medicine 2008;30(2):14-20.
  119. Venkatesh BK, Thirthalli J, Naveen MN, Kishorekumar KV, Arunachala U, Venkatasubramanian G, Subbakrishna DK, Gangadhar BN. Sex difference in age of onset of schizophrenia: findings from a community-based study in India. World Psychiatry 2008 Oct;7(3):173-6.
  120. Rao NP, Venkatasubramanian G, Gangadhar BN. Treatment of Cognitive Deficits in Schizophrenia With Atomoxetine: A Case Report. J Clin Psychiatry 2007;68(12):1988-1989.
  121. Venkatasubramanian G. Schizophrenia is a disorder of aberrant neurodevelopment: A Synthesis of Evidence from Clinical & Structural, Functional and Neurochemical Brain Imaging Studies. Indian J Psychiatry 2007;49(4): 262-267.
  122. Venkatasubramanian G, Chittiprol S, Neelakantachar N, Naveen MN, Thirthalli J, Gangadhar BN, Shetty KT. Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia. Am J Psychiatry. 2007 Oct;164(10):1557-60.
  123. Behere RV, Venkatasubramanian G, Naveen MN, Gangadhar BN. Aripiprazole induced hyponatremia: a case report. Journal of Clinical Psychiatry 2007;68(4): 640-1. 
  124. Hunter MD, VenkatasubramanianGanesan, Wilkinson ID, Spence SA. Impact of Modafinil on Prefrontal Executive Function in Schizophrenia. American Journal of Psychiatry 2006;163(12):2184-2186. 
  125. Jayakumar PN, Venkatasubramanian G, Keshavan MS, Srinivas JS, Gangadhar BN. MRI Volumetric and 31P MRS Metabolic Correlates of Caudate Nucleus in Antipsychotic-naïve schizophrenia. ActaPsychiatricaScandinavica 2006; Nov;114(5):346-51. 
  126. Varambally S, Venkatasubramanian G, Jagadisha T, Gangadhar BN. Cerebellar & other neurological soft signs in antipsychotic-naïve schizophrenia. ActaPsychiatricaScandinavica 2006; 114(5):352-6. 
  127. Gangadhar BN, Jayakumar PN, Venkatasubramanian G, Janakiramaiah N, Keshavan MS. Developmental Reflexes and 31P Magnetic Resonance Spectroscopy of Basal Ganglia in Antipsychotic-Naive Schizophrenia. Progress in Neuropsychopharmacology& Biological Psychiatry 2006; 30(5):910-913. 
  128. VenkatasubramanianGanesan, Hunter MD, Spence SA. Schneiderian first rank symptoms are associated with right parietal hyperactivation: A replication utilising fMRI. American Journal of Psychiatry 2005;162(8):1545.
  129. Jayakumar, PN, Venkatasubramanian G, Gangadhar, BN, Janakiramaiah N, Keshavan, MS.  Optimized Voxel-Based MorphometryOfGray Matter Volume In First-episode, Antipsychotic-naïve Schizophrenia. Progress In Neuropsychopharmacology& Biological Psychiatry 2005;29:587-591. 
  130. Venkatasubramanian G, Green RDJ, Hunter MD, Wilkinson ID, Spence S. Expanding the response space in chronic schizophrenia: the role of left prefrontal cortex. NeuroImage 2005;15;25(3):952-7.
  131. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Janakiramaiah N, Keshavan MS. Striato-cerebellar abnormalities in never-treated Schizophrenia. German J Psychiatry 2003 6(1); 1-7.
  132. Venkatasubramanian G, Latha V, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Jayakumar PN, Keshavan MS Neurological Soft Signs in Never-treated Schizophrenia. ActaPsychiatricaScandinavica 2003;108(2):144-146. 
  133. VenkatasubramanianG, Jayakumar PN, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Keshavan MS. Measuring the corpus callosum in schizophrenia: A technique with neuroanatomical and cytoarchitectural basis. Neurology India 2003;51(2):189-192.
  134. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Janakiramaiah N, Keshavan MS. Reduced Caudate Volume in Never-treated Schizophrenia: Evidence for neurodevelopmental etiopathogenesis. Indian Journal of Psychiatry 2003;45:2.
  135. Chandra PS, Venkatasubramanian G, Thomas T. Infanticidal ideas and infanticidal behavior in Indian women with severe postpartum psychiatric disorders. Journal of Nervous and Mental Disease 2002;190(7):457-461. 
  136. Venkatasubramanian G, Kumar TCR, Khanna S. Obsessive-compulsive disorder and psychosis. Canadian Journal of Psychiatry 2001; 46(8):750-4. 
  137. Venkatasubramanian G, Yogananda BH, Gangadhar. Risperidone-Induced Neuroleptic Malignant Syndrome: A case report. Indian Journal of Psychiatry 2000; 42(1):101-103.
  138. Baspure S, Jagannathan A, Kumar S, Varambally S, Thirthalli J, Venkatasubramanian G, Nagendra HR, Gangadhar BN. Barriers to yoga therapy as an add‑on treatment for schizophrenia in India. International Journal of Yoga 2012;5:70-3.
  139. Thirthalli J, Venkatesh BK, Naveen MN, Venkatasubramanian G, Arunachala U, Kishore Kumar KV, Gangadhar BN. Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community. Indian Journal of Psychiatry 2010 Jan;52(1):37-41.
  140. Reddy NN, Rao NP, Venkatasubramanian G, Arasappa R, Behere RV, Divakaran A, Sivakumar PT, Gangadhar BN. Rimonabant Induced Catatonia in Schizophrenia: A Case Report. Obesity Research & Clinical Practice 2009;3:237-239.




Powered by Create your own unique website with customizable templates.